Acadia Healthcare Company, INC Schedule 13G passive stakes

Khrom Investments Fund, LP, Khrom Capital Management LLC, and Eric Khrom have collectively reported a beneficial ownership of 653,914 shares, representing 0.72% of Acadia Healthcare Company, Inc.

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, disclosing beneficial ownership of 5,015,726.57 shares, representing 5.5% of Acadia Healthcare Co Inc's common stock as of June 30, 2026.

Khrom Capital Management and Eric Khrom have filed a Schedule 13G reporting a 5.66% beneficial ownership stake in Acadia Healthcare Company, Inc.

Wellington Management Group LLP and its affiliates have reported a beneficial ownership of 9.9% of Acadia Healthcare Company, Inc. common stock as of March 31, 2026.

Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting beneficial ownership of 1.6% of Acadia Healthcare Company, Inc.'s common stock as of March 31, 2026.

Vanguard Capital Management has reported a beneficial ownership of 5.25% in Acadia Healthcare Co Inc, holding 4,838,637 shares.

Vanguard Portfolio Management has reported beneficial ownership of 5,079,563 shares, representing 5.51% of Acadia Healthcare Co Inc's common stock, as of March 31, 2026.

The Vanguard Group reports zero beneficial ownership in Acadia Healthcare Co Inc following an internal reporting realignment.

Khrom Investments Fund, Khrom Capital Management, and Eric Khrom collectively reported an 8.09% beneficial ownership in Acadia Healthcare Company, Inc. as of March 10, 2026.

Goldman Sachs Group and its subsidiary Goldman Sachs & Co. LLC have reported a 5.1% beneficial ownership stake in Acadia Healthcare Company, Inc.

Wellington Management Group and its affiliates have reported a significant beneficial ownership stake of 12.8% in Acadia Healthcare Company, Inc. common stock.

The Vanguard Group reported an increased beneficial ownership of 10.19% in Acadia Healthcare Co Inc, holding 9,417,045 shares as of September 30, 2025.

Wellington Management Group LLP and its affiliates filed an amended Schedule 13G, reporting a 10.2% beneficial ownership in Acadia Healthcare Company, Inc. as of September 30, 2025.

BlackRock, Inc. has reported an 11.2% beneficial ownership stake in Acadia Healthcare Company, Inc. common stock.

Wellington Management Group LLP and its affiliates have disclosed a 9.15% beneficial ownership stake in Acadia Healthcare Company, Inc. as of June 30, 2025.

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, disclosing a 1.0% beneficial ownership stake in Acadia Healthcare Company Inc. as of March 31, 2025.

FMR LLC and its affiliates, along with Abigail P. Johnson, have filed a Schedule 13G disclosing a passive beneficial ownership of 6.7% of Acadia Healthcare Co Inc.'s common stock as of December 31, 2024.